Tag pharmacogenetics [at least 200 articles] Export

Recent papers classified by the tag pharmacogenetics.

	Drug effects viewed from a signal transduction network perspective. [My Copy] Journal of medicinal chemistry, Vol. 52, No. 24. (24 December 2009), pp. 8038-8046. by Anton F. Fliri, William T. Loging, Robert A. Volkmann posted to pharmacogenetics drug by guhjy on 2009-12-19 15:07:36 as
	Similar compounds searching system by using the gene expression microarray database. [My Copy] Toxicology letters, Vol. 186, No. 1. (10 April 2009), pp. 52-57. by Hiroyoshi Toyoshiba, Hiroshi Sawada, Ichiro Naeshiro, Akira Horinouchi posted to pharmacogenetics ma drug by guhjy on 2009-12-19 14:58:50 as
	Identifying network of drug mode of action by gene expression profiling. [My Copy] Journal of computational biology : a journal of computational molecular cell biology, Vol. 16, No. 2. (February 2009), pp. 241-251. by Francesco Iorio, Roberto Tagliaferri, Diego di Bernardo posted to pharmacogenetics drug by guhjy on 2009-12-19 14:22:54 as along with 1 person diging_data
	The Connectivity Map: a new tool for biomedical research. [My Copy] Nature reviews. Cancer, Vol. 7, No. 1. (01 January 2007), pp. 54-60. by Justin Lamb posted to pharmacogenetics drug db by guhjy on 2009-12-19 14:15:25 as along with 6 people frohike ipark-kaist bertelsen mingzhi wimufi ndeah
	PharmGKB: understanding the effects of individual genetic variants. [My Copy] Drug metabolism reviews, Vol. 40, No. 4. (2008), pp. 539-551. by Katrin Sangkuhl, Dorit S. Berlin, Russ B. Altman, Teri E. Klein posted to pharmacogenetics kb drug by guhjy on 2009-12-19 12:39:48 as along with 1 person misonneh
	Extraction of genotype-phenotype-drug relationships from text: from entity recognition to bioinformatics application. [My Copy] Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing (2010), pp. 485-487. by Adrien Coulet, Nigam Shah, Lawrence Hunter, Chitta Barral, Russ B. Altman posted to pubmed pharmacogenetics drug by guhjy on 2009-12-19 12:09:57 as
	Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes. [My Copy] Biochimica et biophysica acta, Vol. 1770, No. 3. (March 2007), pp. 489-494. by Julia Kirchheiner, Angela Seeringer posted to review pharmacogenetics design cyp450 clinic 12lecture by misonneh on 2009-12-05 07:24:18 as along with 2 people guhjy skatsanis
	Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment. [My Copy] European journal of clinical pharmacology, Vol. 64, No. 2. (February 2008), pp. 133-157. by Jürgen Brockmöller, Mladen V. Tzvetkov posted to review population phenotype pharmacogenetics methodology genetics design database association 12lecture by misonneh on 2009-12-04 18:06:31 as
	Is this the drug or dose for you? Impact and consideration of ethnic factors in global drug development, regulatory review, and clinical practice. [My Copy] Clinical pharmacology and therapeutics, Vol. 84, No. 3. (September 2008), pp. 287-294. by S-M M. Huang, R. Temple posted to review race practice pharmacogenetics gxe clinic by misonneh on 2009-12-04 15:28:30 as
	Clustering and its application in multi-target prediction. [My Copy] Current opinion in drug discovery & development, Vol. 12, No. 1. (January 2009), pp. 98-107. by William Liu, Dale E. Johnson posted to pharmacogenetics database data_mining cyp450 by misonneh on 2009-11-30 07:38:54 as along with 1 person ramensky
	Association of thymidylate synthase variants with 5-fluorouracil cytotoxicity. [My Copy] Pharmacogenetics and genomics, Vol. 19, No. 5. (May 2009), pp. 399-401. by Eric J. Peters, Aldi T. Kraja, Shiow J. Lin, et al.Jane L. Yen-Revollo, Sharon Marsh, Michael A. Province, Howard L. McLeod posted to pharmacogenetics pbmc hapmap by guhjy on 2009-11-28 16:19:04 as
	Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers. [My Copy] PloS one, Vol. 4, No. 11. (2009) by Liang Li, Brooke L. Fridley, Krishna Kalari, et al.Gregory Jenkins, Anthony Batzler, Richard M. Weinshilboum, Liewei Wang posted to pharmacogenetics pbmc hapmap by guhjy on 2009-11-28 16:15:49 as
	A pharmacogene database enhanced by the 1000 Genomes Project. [My Copy] Pharmacogenetics and genomics, Vol. 19, No. 10. (9 October 2009), pp. 829-832. by Eric R. Gamazon, Wei Zhang, R. Stephanie Huang, M. Eileen Dolan, Nancy J. Cox posted to pharmacogenetics hapmap by guhjy on 2009-11-28 16:03:24 as along with 1 person misonneh
	Allelic, genotypic and phenotypic distributions of S-mephenytoin 4'-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the world. [My Copy] Pharmacogenetics, Vol. 9, No. 5. (October 1999), pp. 539-549. by H. G. Xie, C. M. Stein, R. B. Kim, G. R. Wilkinson, D. A. Flockhart, A. J. Wood posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 12:00:28 as
	Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method. [My Copy] Pharmacogenetics, Vol. 10, No. 5. (July 2000), pp. 373-388. by V. Ozdemir, W. Kalow, B. K. Tang, et al.A. D. Paterson, S. E. Walker, L. Endrenyi, A. D. Kashuba posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:59:25 as
	Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. [My Copy] Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Vol. 27, No. 1. (July 2002), pp. 105-119. by Bernard Lerer, Ronnen H. Segman, Heiner Fangerau, et al.Ann K. Daly, Vincenzo S. Basile, Roberto Cavallaro, Harald N. Aschauer, Robin G. McCreadie, Stephanie Ohlraun, Nicol Ferrier, Mario Masellis, Massimiliano Verga, Joachim Scharfetter, Marcella Rietschel, Roger Lovlie, Uriel Heresco H. Levy, Herbert Y. Meltzer, James L. Kennedy, Vidar M. Steen, Fabio Macciardi posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:56:36 as
	CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis. [My Copy] Genetics in medicine : official journal of the American College of Medical Genetics, Vol. 7, No. 2. (February 2005), pp. 97-104. by Simon Sanderson, Jon Emery, Julian Higgins posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:54:27 as
	Pharmacogenetics of antipsychotic therapy: pivotal research issues and the prospects for clinical implementation. [My Copy] Dialogues in clinical neuroscience, Vol. 8, No. 1. (2006), pp. 85-94. by Bernard Lerer, Ronnen H. Segman posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:54:09 as
	Pharmacogenomic effect of cytochrome P450 2C9 polymorphisms in different populations. [My Copy] Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, Vol. 12, No. 2. (April 2006), pp. 219-222. by Viroj Wiwanitkit posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:51:20 as
	Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis. [My Copy] The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP), Vol. 10, No. 5. (October 2007), pp. 697-704. by Vincenzo De Luca, Daniel J. Mueller, Andrea de Bartolomeis, James L. Kennedy posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:50:52 as
	Assessing theoretical risk and benefit suggested by genetic association studies of CCR5: experience in a drug development programme for maraviroc. [My Copy] Antiviral therapy, Vol. 12, No. 2. (2007), pp. 233-245. by Jeremy Wheeler, Mary McHale, Vicky Jackson, Michelle Penny posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:50:26 as
	Meta-analysis: Inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease. [My Copy] Alimentary pharmacology & therapeutics, Vol. 26, No. 5. (1 September 2007), pp. 643-652. by J. M. Van Dieren, B. E. Hansen, E. J. Kuipers, E. E. Nieuwenhuis, C. J. Van der Woude posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:47:28 as
	Association of antipsychotic induced weight gain and body mass index with GNB3 gene: a meta-analysis. [My Copy] Progress in neuro-psychopharmacology & biological psychiatry, Vol. 32, No. 8. (12 December 2008), pp. 1848-1853. by Renan P. Souza, Vincenzo De Luca, Giovanni Muscettola, et al.Daniela V. Rosa, Andrea de Bartolomeis, Marco Romano Silva, James L. Kennedy posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:45:45 as
	Influence of CYP2C9 genotype on warfarin dose requirements--a systematic review and meta-analysis. [My Copy] European journal of clinical pharmacology, Vol. 65, No. 4. (April 2009), pp. 365-375. by Jonatan D. Lindh, Lennart Holm, Marine L. Andersson, Anders Rane posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:43:55 as
	Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity. [My Copy] The Journal of rheumatology, Vol. 36, No. 3. (March 2009), pp. 539-545. by Mark C. Fisher, Bruce N. Cronstein posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:40:38 as
	TNF-alpha-308 G/A polymorphism and responsiveness to TNF-alpha blockade therapy in moderate to severe rheumatoid arthritis: a systematic review and meta-analysis. [My Copy] The pharmacogenomics journal, Vol. 9, No. 3. (14 June 2009), pp. 161-167. by D. D. O'Rielly, N. M. Roslin, J. Beyene, A. Pope, P. Rahman posted to pharmacogenetics meta_analysis kfdap_112909 by misonneh on 2009-11-27 11:40:03 as
	ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation. [My Copy] BMC medical genetics, Vol. 10 (04 June 2009), 50. by Georgios Kitsios, Elias Zintzaras posted to response pharmacogenetics meta_analysis genetics by misonneh on 2009-11-27 09:08:07 as
	Common ABCB1 polymorphisms are not associated with multidrug resistance in epilepsy using a gene-wide tagging approach. [My Copy] Pharmacogenetics and genomics, Vol. 17, No. 3. (March 2007), pp. 217-220. by Guy D. Leschziner, Toby Andrew, John Paul P. Leach, et al.David Chadwick, Alison J. Coffey, David J. Balding, David R. Bentley, Munir Pirmohamed, Michael R. Johnson posted to response resistance pharmacogenetics mdr1 gwas genetics epilepsy by misonneh on 2009-11-27 08:46:17 as
	Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer. [My Copy] The lancet oncology, Vol. 9, No. 10. (October 2008), pp. 962-972. by Helena Linardou, Issa J. Dahabreh, Dimitra Kanaloupiti, et al.Fotios Siannis, Dimitrios Bafaloukos, Paris Kosmidis, Christos A. Papadimitriou, Samuel Murray posted to review response pharmacogenetics meta_analysis genetics egfr_pathway by misonneh on 2009-11-27 08:42:08 as along with 1 person jfr
	Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis. [My Copy] Epilepsia, Vol. 50, No. 4. (April 2009), pp. 898-903. by Facundo Garcia G. Bournissen, Myla E. Moretti, David N. Juurlink, Gideon Koren, Mugabe Walker, Yaron Finkelstein posted to review response pharmacogenetics meta_analysis mdr1 genetics epilepsy by misonneh on 2009-11-27 08:37:06 as
	Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy [My Copy] Nature Genetics, Vol. 41, No. 12. (08 November 2009), pp. 1345-1349. by Colin J. D. Ross, Hagit Katzov-Eckert, Marie-Pierre Dube, et al.Beth Brooks, S. Rod Rassekh, Amina Barhdadi, Yassamin Feroz-Zada, Henk Visscher, Andrew M. K. Brown, Michael J. Rieder, Paul C. Rogers, Michael S. Phillips, Bruce C. Carleton, Michael R. Hayden posted to tpmt pharmacogenetics journal_club comt cisplatin chemotherapy association adr by misonneh on 2009-11-25 07:01:55 as
	Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 21, No. 21. (1 November 2003), pp. 3940-3947. by Wen-Kai K. Weng, Ronald Levy posted to trastuzumab pharmacogenetics lymphoma her2 fcr3a fcr2a cancer by songpku on 2009-11-24 18:34:18 as
	FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 25, No. 24. (20 August 2007), pp. 3712-3718. by Wu Zhang, Michael Gordon, Anne M. Schultheis, et al.Dong Yun Y. Yang, Fumio Nagashima, Mizutomo Azuma, Heung-Moon M. Chang, Eva Borucka, Georg Lurje, Andy E. Sherrod, Syma Iqbal, Susan Groshen, Heinz-Josef J. Lenz posted to trastuzumab pharmacogenetics her2 fcgr3a fcgr2a colorectal cancer by songpku on 2009-11-24 18:30:34 as
	Genetic polymorphisms of the CYP19A1 gene and breast cancer survival. [My Copy] Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 15, No. 11. (November 2006), pp. 2115-2122. by Ji-Rong R. Long, Nobuhiko Kataoka, Xiao-Ou O. Shu, et al.Wanqing Wen, Yu-Tang T. Gao, Qiuyin Cai, Wei Zheng posted to survival polymorphism pharmacogenetics cyp19a1 cancer breast by songpku on 2009-11-24 17:22:38 as
	Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival. [My Copy] Pharmacogenetics and genomics, Vol. 17, No. 5. (May 2007), pp. 331-338. by Ji-Rong R. Long, Qiuyin Cai, Xiao-Ou O. Shu, Hui Cai, Yu-Tang T. Gao, Wei Zheng posted to polymorphism pharmacogenetics cyp1a2 cyp1a1 cancer breast by songpku on 2009-11-24 04:53:38 as along with 1 person and 1 group carore Asian Pharmacogenetics Library
	CYP1A1 polymorphisms modify overall survival in acute myeloid leukemia patients. [My Copy] Leukemia & lymphoma, Vol. 48, No. 6. (June 2007), pp. 1211-1215. by Luís Arthur Flores A. Pelloso, Ismael Dale Cotrim Guerreiro D. Da Silva, Naiara Côrrea Nogueira C. De Souza, Mihoko Yamamoto, Carlos Alberto Oliveira A. Botelho, Maria De Lourdes Ferrari d. e. . L. Chauffaille posted to survival polymorphism pharmacogenetics leukemia cyp1a1 by songpku on 2009-11-24 04:46:09 as
	Nitric Oxide Synthase Variants and Disease-Free Survival among Treated and Untreated Breast Cancer Patients in a Southwest Oncology Group Clinical Trial [My Copy] Clinical Cancer Research, Vol. 15, No. 16. (15 August 2009), pp. 5258-5266. by Ji-Yeob Choi, William E. Barlow, Kathy S. Albain, et al.Chi-Chen Hong, Javier G. Blanco, Robert B. Livingston, Warren Davis, James M. Rae, I-Tien Yeh, Laura F. Hutchins, Peter M. Ravdin, Silvana Martino, Alan P. Lyss, C. Kent Osborne, Martin D. Abeloff, Daniel F. Hayes, Christine B. Ambrosone posted to survival pharmacogenetics nos cancer breast ambrosone by songpku on 2009-11-24 03:28:41 as along with 1 person misonneh
	Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. [My Copy] Pharmacogenomics, Vol. 5, No. 7. (October 2004), pp. 895-931. by Joseph F. Solus, Brenda J. Arietta, James R. Harris, et al.David P. Sexton, John Q. Steward, Chara McMunn, Patrick Ihrie, Janelle M. Mehall, Todd L. Edwards, Elliott P. Dawson posted to variant racial polymorphism phase pharmacogenetics i genetic difference cyp by songpku on 2009-11-23 21:22:40 as along with 5 people and 1 group YinJinJang jjing03 kjkj0001 parkjs80 carore Asian Pharmacogenetics Library
	Pharmacokinetics and toxicity of docetaxel: Role of CYP3A, MDR1, and GST polymorphisms [My Copy] Clinical Pharmacology & Therapeutics, Vol. 79, No. 6. (01 June 2006), pp. 570-580. by A. Tran, V. Jullien, J. Alexandre, et al.E. Rey, F. Rabillon, V. Girre, V. Dieras, G. Pons, F. Goldwasser, J. M. Treluyer posted to variant taxane pharmacogenetics genetic cancer breast by songpku on 2009-11-23 00:14:38 as
	Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen [My Copy] JAMA, Vol. 302, No. 13. (7 October 2009), pp. 1429-1436. by Werner Schroth, Matthew P. Goetz, Ute Hamann, et al.Peter A. Fasching, Marcus Schmidt, Stefan Winter, Peter Fritz, Wolfgang Simon, Vera J. Suman, Matthew M. Ames, Stephanie L. Safgren, Mary J. Kuffel, Hans U. Ulmer, Julia Bolander, Reiner Strick, Matthias W. Beckmann, Heinz Koelbl, Richard M. Weinshilboum, James N. Ingle, Michel Eichelbaum, Matthias Schwab, Hiltrud Brauch posted to tamoxifen polymorphism pharmacogenetics cyp2d6 cancer breast by songpku on 2009-11-22 22:54:50 as along with 2 people misonneh merpublic
	ABCB1 Pharmacogenetics: Progress, Pitfalls, and Promise [My Copy] Clinical Pharmacology & Therapeutics, Vol. 81, No. 2. (01 February 2007), pp. 265-269. by L. W. Chinn, D. L. Kroetz posted to review pharmacogenetics mdr1 by misonneh on 2009-11-19 05:48:32 as
	Paving the Critical Path: How can Clinical Pharmacology Help Achieve the Vision? [My Copy] Clinical Pharmacology & Therapeutics, Vol. 81, No. 2. (01 February 2007), pp. 170-177. by L. J. Lesko posted to pharmacogenetics perspective design comments by misonneh on 2009-11-19 05:41:44 as along with 1 person rwinegar
	The Prospects for \|[ldquo]\|Personalized Medicine\|[rdquo]\| in Drug Development and Drug Therapy [My Copy] Clinical Pharmacology & Therapeutics, Vol. 81, No. 2. (01 February 2007), pp. 164-169. by J. Woodcock posted to review pharmacogenetics perspective design by misonneh on 2009-11-19 05:39:07 as
	Genetic matters of CYP2D6 in breast cancer: copy number variations and nucleotide polymorphisms [My Copy] Nat Rev Cancer, Vol. 9, No. 11. (23 October 2009), pp. 842-843. by Ke-Da Yu, Zhi-Ming Shao posted to tamoxifen review pharmacogenetics genetics cyp2d6 comments breast by misonneh on 2009-11-19 05:26:25 as
	Genomics: We are individuals [My Copy] Nat Rev Cancer, Vol. 9, No. 11. (01 November 2009), pp. 770-771. by Gemma K. Alderton posted to technology subtypes pharmacogenetics metastasis genetics dynamic comments breast biomarker by misonneh on 2009-11-19 02:18:41 as
	Current Understanding of the Pharmacogenomics of Metformin [My Copy] Clinical Pharmacology & Therapeutics, Vol. 86, No. 6. (01 December 2009), pp. 595-598. by O. Zolk posted to transport review pharmacogenetics metformin comments by misonneh on 2009-11-18 02:40:31 as
	Pharmacogenetics and pharmacogenomics of anticancer agents. [My Copy] CA: a cancer journal for clinicians, Vol. 59, No. 1. (1 January 2009), pp. 42-55. by R. Stephanie Huang, Mark J. Ratain posted to pharmacogenetics cancer by guhjy on 2009-11-15 02:45:32 as along with 1 person songpku
	Pharmacogenomics. [My Copy] Methods in molecular biology (Clifton, N.J.), Vol. 520 (2009), pp. 231-245. by Shilong Zhong, Marjorie Romkes posted to pharmacogenetics by guhjy on 2009-11-15 02:44:50 as
	The education potential of the pharmacogenetics and pharmacogenomics knowledge base (PharmGKB). [My Copy] Clinical pharmacology and therapeutics, Vol. 82, No. 4. (22 October 2007), pp. 472-475. by R. P. Owen, T. E. Klein, R. B. Altman posted to pharmacogenetics database by misonneh on 2009-11-10 08:28:55 as along with 1 person psique
	The PharmGKB: integration, aggregation, and annotation of pharmacogenomic data and knowledge. [My Copy] Clinical pharmacology and therapeutics, Vol. 81, No. 1. (January 2007), pp. 21-24. by A. E. Hodge, R. B. Altman, T. E. Klein posted to pharmacogenetics database by misonneh on 2009-11-10 08:28:02 as

Note: You may cite this page as: http://www.citeulike.org/tag/pharmacogenetics

Result page: 1 2 3 4 5 6 7 Next

review	81
breast	63
tamoxifen	33
cancer	31
genetics	29
cyp2d6	22
adr	19
polymorphism	19
cyclophosphamide	18
drug	16
meta_analysis	16
comments	15
chemotherapy	13
kfdap_112909	13
cyp3a4	12
epigenetics	12
metabolism	12
survival	12
gwas	11
personalized-medicine	11
cyp2b6	10
race	10
resistance	10
toxicity	10
database	9
gsta1	9
prediction	9
response	9
biomarker	8
gstp1	8
hla	8
clinic	7
cyp450	7
epistasis	7
genotype	7
perspective	7
pk	7
prognosis	7
carbamazepine	6
design	6
hapmap	6
mdr1	6
phenotype	6
therapy	6
epilepsy	5
methylation	5
ugt	5
ambrosone	4
association	4
colon	4
ddi	4
fda	4
genetic	4
genetic-testing	4
lung	4
microrna	4
mnsod	4
modeling	4
pbmc	4
pharmacogenomics	4
population-genetics	4
snp	4
translation	4
12lecture	3
circ_dna	3
cocaine	3
cyp	3
data_mining	3
db	3
dna	3
drug_x_expression	3
ethical-issues	3
expectations	3
expression	3
gene_specific_methylation	3
gxg	3
irinotecan	3
lymphoma	3
ma	3
mirna	3
pathway	3
pubmed	3
repair	3
serotonin	3
taxane	3
warfarin	3
2d6	2
ad	2
asian_populations	2
breast-cancer	2
clinical	2
genome	2
ngas	2
public	2
risk	2
technology	2
tpmt	2
translational	2
variant	2
xpd	2

Tag pharmacogenetics [at least 200 articles] Export

Related Tags